Ingrid Sollerer has been General Counsel and Global Head of Legal at Sandoz since February 2019 and is a member of the Sandoz Executive Committee. She is responsible for all aspects of legal affairs across the company.
Ingrid joined Novartis in Austria in 1998, followed by seven years in the Novartis Group M&A and Antitrust teams in Basel. She joined Sandoz in 2007, heading Legal for Europe, Africa, and the Middle East, and taking on global legal responsibility for anti-infectives, oncology injectables, and biopharmaceuticals. In 2016 she joined Novartis Oncology in the US as Global Head Legal Oncology Strategy and Business Development, and Cell & Gene.
As a global leader in generics and biosimilars, Sandoz continues to challenge existing frameworks and to shape an environment that improves healthcare systems for the benefit of patients around the world. To do this, it’s essential to take a holistic approach to legal affairs affecting the industry overall.
Ingrid holds a Doctorate in Law from Leopold-Franzens University in Innsbruck, Austria, during which she spent a year on an Erasmus exchange at the University of Seville, Spain. She has additionally completed courses in Finance from the Harvard Business School and in Healthcare Systems from the Harvard T.H. Chan School of Public Health. Since 2019, Ingrid has been a Board Member of Medicines for Europe. She also chairs the Board of Stiftung Menschen für Menschen Karlheinz Böhms Äthiopienhilfe, an organization providing aid for self-development in Ethiopia. In her free time Ingrid enjoys opera, running, skiing and sailing.